Metamodix, Inc, based in Minneapolis, MN, is a dedicated company focused on reducing the human and financial burdens associated with metabolic diseases. Their innovative product, the EndoSleeve, offers a safer and more cost-effective treatment option for patients suffering from Type 2 Diabetes, Obesity, and NASH.
Currently undergoing preliminary clinical evaluation outside the US, the EndoSleeve is not yet approved for sale in any geography worldwide. Metamodix, Inc aims to provide a solution that addresses the underlying technology behind metabolic diseases, offering hope for improved patient outcomes.
Generated from the website